206 related articles for article (PubMed ID: 23908254)
1. Sarcoma chemotherapy.
Walczak BE; Irwin RB
J Am Acad Orthop Surg; 2013 Aug; 21(8):480-91. PubMed ID: 23908254
[TBL] [Abstract][Full Text] [Related]
2. [Soft tissue sarcoma: postoperative chemotherapy].
Goto T; Kosaku H; Kobayashi H; Hozumi T; Kondo T
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1324-30. PubMed ID: 15446551
[TBL] [Abstract][Full Text] [Related]
3. [Preoperative adjuvant therapy for primary malignant bone tumors].
Goto T; Okuma T; Nakada I; Hozumi T; Kondo T
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1750-4. PubMed ID: 18030009
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy of advanced bone and soft tissue sarcoma].
Yamawaki S; Isu K; Ubayama Y; Yamaguti H; Gotou M
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1757-63. PubMed ID: 6541020
[TBL] [Abstract][Full Text] [Related]
5. Current perspectives in the management of soft-tissue sarcoma. The role of chemotherapy in multimodality therapy.
Bramwell VH
Can J Surg; 1988 Nov; 31(6):390-6. PubMed ID: 3052763
[TBL] [Abstract][Full Text] [Related]
6. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
Demetri GD; Elias AD
Hematol Oncol Clin North Am; 1995 Aug; 9(4):765-85. PubMed ID: 7490240
[TBL] [Abstract][Full Text] [Related]
7. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
[TBL] [Abstract][Full Text] [Related]
8. [Medical treatment of soft-tissue sarcomas in adults].
Lucas P; Spielmann M
Bull Cancer; 1985; 72(3):183-201. PubMed ID: 3907733
[TBL] [Abstract][Full Text] [Related]
9. High-dose ifosfamide in the treatment of sarcomas of soft tissues and bone.
Demetri GD
Semin Oncol; 1996 Jun; 23(3 Suppl 6):22-6. PubMed ID: 8677444
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
Pappo AS; Devidas M; Jenkins J; Rao B; Marcus R; Thomas P; Gebhardt M; Pratt C; Grier HE
J Clin Oncol; 2005 Jun; 23(18):4031-8. PubMed ID: 15767644
[TBL] [Abstract][Full Text] [Related]
11. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.
Wexler LH; DeLaney TF; Tsokos M; Avila N; Steinberg SM; Weaver-McClure L; Jacobson J; Jarosinski P; Hijazi YM; Balis FM; Horowitz ME
Cancer; 1996 Aug; 78(4):901-11. PubMed ID: 8756388
[TBL] [Abstract][Full Text] [Related]
12. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
[TBL] [Abstract][Full Text] [Related]
13. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
[TBL] [Abstract][Full Text] [Related]
14. [Combination chemotherapy with vincristin, actinomycin D, cyclophosphamide and adriamycin in soft-part sarcoma].
Mori O; Takagi K; Kitagawa T; Harada M; Ogawa I
Gan No Rinsho; 1986 Aug; 32(9):998-1004. PubMed ID: 3747164
[TBL] [Abstract][Full Text] [Related]
15. [Results of chemotherapy of soft tissue sarcoma in adults].
Santoro A; Viviani S
Radiol Med; 1984 Nov; 70(11):893-5. PubMed ID: 6399763
[No Abstract] [Full Text] [Related]
16. Appraising the current role of chemotherapy for the treatment of sarcoma.
D'Adamo DR
Semin Oncol; 2011 Oct; 38 Suppl 3():S19-29. PubMed ID: 22055968
[TBL] [Abstract][Full Text] [Related]
17. Targeted Chemotherapy in Bone and Soft-Tissue Sarcoma.
Harwood JL; Alexander JH; Mayerson JL; Scharschmidt TJ
Orthop Clin North Am; 2015 Oct; 46(4):587-608. PubMed ID: 26410647
[TBL] [Abstract][Full Text] [Related]
18. Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma Group.
Blackledge G; Steward WP; Verweij J; Mouridsen H; Bramwell V; Schütte J; van Oosterom A; Dombernowsky P; Buesa J; Van Glabekke M
Semin Oncol; 1992 Feb; 19(1 Suppl 1):14-8. PubMed ID: 1411615
[TBL] [Abstract][Full Text] [Related]
19. The role of ifosfamide in the treatment of sarcomas.
Dirix LY; Van Oosterom AT
Semin Oncol; 1989 Feb; 16(1 Suppl 3):39-45. PubMed ID: 2649984
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
Yap BS; Baker LH; Sinkovics JG; Rivkin SE; Bottomley R; Thigpen T; Burgess MA; Benjamin RS; Bodey GP
Cancer Treat Rep; 1980 Jan; 64(1):93-8. PubMed ID: 7379060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]